Amgen Inc. (AMGN) Raises Dividend 15% & Offers A Compelling Valuation

Jan. 03, 2017 2:32 PM ETAMGN
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Dividend Investing, Dividend Growth Investing, Contrarian

Contributor Since 2012

Mr. McIntosh is the author of the three investment books including the newly released "The Snowball Effect,  "The Sector Strategist", and also "The Bear Market Survival Guide". He is a portfolio manager at PVG Asset Management where he manages the firm's U.S. Corporate Flexible Bond Portfolio as well as a Large Cap Value portfolio. 

He also served as a Professor of Finance at Eckerd College from 1998 to 2008. He has been featured in such notable publications as the Wall Street Journal, New York Times, USA Today, Investment Advisor, Fortune, and The St. Petersburg Times.  He holds a Bachelor of Science Degree in Economics from Florida State University, a Master of Business Administration (M.B.A) from the University of Sarasota, and a Master of Public Health Degree (M.P.H) from the University of South Florida. He and his wife and two boys reside in Tampa, Florida.

Amgen's (AMGN) dividend was increased by a stellar 15% on December 21st. Its overall yield is 3.15%. The firm started paying a dividend in 2011. Amgen is the world's largest independent biotechnology firm. The healthcare company develops and manufactures a multitude of products for health ailments. Amgen is a true leaders in its field… Click here to finish reading this article by The Dividend Manager...

Disclosure: I am/we are long AMGN.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.